Alto Neuroscience
Financial ratios & Valuation

Historical Multiples (2021 – 2023)

2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-57.62-19.10-15.32N/A-19.10
Price/Sales ratio
2.52KN/AN/AN/AN/A
Price/Book Value ratio
-42.42-13.78-7.76N/A-13.78
Price/Cash Flow ratio
-57.15-25.95-16.63N/A-25.95
Price/Free Cash Flow ratio
-53.24-25.05-16.40N/A-25.05
Price/Earnings Growth ratio
N/A-0.09-0.61N/A-0.09
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
30.95%N/AN/AN/AN/A
Operating Profit Margin
-5740.95%N/AN/AN/AN/A
Pretax Profit Margin
-4374.76%N/AN/AN/AN/A
Net Profit Margin
-4374.76%N/AN/AN/AN/A
Effective Tax Rate
N/AN/AN/AN/AN/A
Return on Assets
-31.90%-54.48%-41.90%N/A-54.48%
Return On Equity
73.62%72.15%50.65%N/A72.15%
Return on Capital Employed
-44.67%-64.45%-46.66%N/A-64.45%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A
Quick Ratio
15.298.8515.22N/A8.85
Cash ratio
14.208.6914.71N/A8.69
Days of Sales Outstanding
3.02KN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A
Operating Cycle
3.02KN/AN/AN/AN/A
Days of Payables Outstanding
1.51K1.71K1.05KN/A1.71K
Cash Conversion Cycle
1.51KN/AN/AN/AN/A
Debt Ratios
Debt Ratio
1.321.600.11N/A1.60
Debt Equity Ratio
-3.05-2.12-0.13N/A-2.12
Long-term Debt to Capitalization
1.481.88-0.15N/A1.88
Total Debt to Capitalization
1.481.88-0.15N/A1.88
Interest Coverage Ratio
N/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.24-0.24-3.39N/A-0.24
Company Equity Multiplier
-2.30-1.32-1.20N/A-1.32
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-44.10N/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.071.031.01N/A1.03
Cash Flow Coverage Ratio
-0.24-0.24-3.39N/A-0.24
Short Term Coverage Ratio
N/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/A